5alpha-reductase inhibitors.
Rittmaster
R S
RS
Dalhousie University and the Queen Elizabeth II Health Sciences Centre, Nova Scotia, Canada.
D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism; D058891:5-alpha Reductase Inhibitors; D013196:Dihydrotestosterone / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011467:Prostate / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000188:drug therapy; D013739:Testosterone / Q000378:metabolism
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D013196:Dihydrotestosterone; D013739:Testosterone; D018120:Finasteride; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase